Israel Englander Cytokinetics Inc Call Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$51.22 - $60.16 $911,716 - $1.07 Million	-17,800 Reduced 35.6%	32,200 $1.7 Million
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $378,094 - $592,895	-7,900 Reduced 13.64%	50,000 $2.71 Million
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $7.85 Million - $13.3 Million	-123,200 Reduced 68.03%	57,900 $4.06 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $4.87 Million - $15.1 Million	181,100 New	181,100 $15.1 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $894,250 - $1.28 Million	25,000 New	25,000 $1.15 Million

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.46B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.